Semac Consultants Limited (SEMAC.BO)
INR 383.2
(0.0%)
INR 383.2
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.27 Billion | 3.25 Billion | 795.95 Million | 1.32 Billion | 1.58 Billion | 2.1 Billion |
| Cost of Revenue | 1.16 Billion | 2.41 Billion | 298.02 Million | 494.42 Million | 611.6 Million | 1.04 Billion |
| Gross Profit | 111.35 Million | 836.65 Million | 497.92 Million | 826.88 Million | 975.69 Million | 1.05 Billion |
| Operating Expenses | 305.52 Million | 576.67 Million | 506.54 Million | 673.63 Million | 772.42 Million | 893.18 Million |
| Selling, General and Administrative Expenses | 73.08 Million | 67.31 Million | 53.19 Million | 114.11 Million | 138.44 Million | 162.94 Million |
| Research and Development Expenses | - | - | 5.22 Million | 4.07 Million | 1.33 Million | 16.59 Million |
| Other Expenses | 38.26 Million | 3.62 Million | 7.28 Million | 9.91 Million | 16.18 Million | 11.25 Million |
| Cost and Expenses | 1.47 Billion | 2.99 Billion | 804.57 Million | 1.16 Billion | 1.38 Billion | 1.93 Billion |
| Operating Income | -199.72 Million | 253.55 Million | -11.24 Million | 59.36 Million | 174.16 Million | 150.02 Million |
| Interest Expense | 13.48 Million | 4.8 Million | 4.5 Million | 25.21 Million | 6.09 Million | 14.97 Million |
| Income Tax Expense | -8.46 Million | 80.07 Million | -7.79 Million | 45.15 Million | 53.42 Million | 20.42 Million |
| Earnings before Tax | -327.33 Million | 272.63 Million | 17.82 Million | 71.23 Million | 214.57 Million | 152.25 Million |
| Net Income | -323.31 Million | 183.5 Million | 22.15 Million | 52.16 Million | 150.05 Million | 115.34 Million |
| Earnings Per Share Basic | -103.72 | 58.87 | 7.11 | 17.01 | 48.93 | 37.61 |
| Earnings Per Share Diluted | -103.72 | 58.87 | 7.11 | 17.01 | 48.93 | 37.61 |
| Weighted Average Shares Outstanding | 3.11 Million | 3.11 Million | 3.11 Million | 3.06 Million | 3.06 Million | 3.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.11 Million | 3.11 Million | 3.11 Million | 3.06 Million | 3.06 Million | 3.06 Million |
| Gross Margin | 0.09 | 0.26 | 0.63 | 0.63 | 0.61 | 0.50 |
| EBIT Margin | -0.23 | 0.09 | 0.06 | 0.16 | 0.16 | 0.10 |
| Profit Margin | -0.25 | 0.06 | 0.03 | 0.04 | 0.09 | 0.05 |
| EBITDA | -291.25 Million | 305.53 Million | 42.38 Million | 120.88 Million | 254.5 Million | 194.53 Million |
| Earnings Before Tax Margin | -0.16 | 0.08 | -0.01 | 0.04 | 0.11 | 0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 325.17 Million | 209.82 Million | 249.89 Million | 1.27 Billion | 275.13 Million | 228.73 Million |
| Cost of Revenue | 251.87 Million | 205.93 Million | 317.93 Million | 1.47 Billion | 359.03 Million | 144.24 Million |
| Gross Profit | 73.29 Million | 3.89 Million | -68.04 Million | -204.68 Million | -83.89 Million | 84.49 Million |
| Operating Expenses | 84.07 Million | 23.66 Million | 54.93 Million | 158.6 Million | 123.42 Million | 115.68 Million |
| Selling, General and Administrative Expenses | 20.81 Million | 23.66 Million | 54.93 Million | - | 32.04 Million | 34.96 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 84.07 Million | 6.84 Million | 9.82 Million | 55.46 Million | 3.64 Million | 7.25 Million |
| Cost and Expenses | 335.95 Million | 229.59 Million | 372.87 Million | 1.63 Billion | 482.45 Million | 259.93 Million |
| Operating Income | -10.78 Million | -19.77 Million | -122.98 Million | -363.28 Million | -203.78 Million | -31.19 Million |
| Interest Expense | 13.32 Million | 10.04 Million | 5.42 Million | 18.24 Million | 5.92 Million | 2.92 Million |
| Income Tax Expense | 12.94 Million | 644 Thousand | 41.44 Million | -8.46 Million | -64.77 Million | 6.16 Million |
| Earnings before Tax | -16.74 Million | -22.97 Million | -118.58 Million | -326.06 Million | -209.7 Million | -26.94 Million |
| Net Income | -30.74 Million | -24.83 Million | -160.19 Million | -323.31 Million | -144.94 Million | -34.98 Million |
| Earnings Per Share Basic | -9.53 | -8.10 | -52.23 | - | -47.26 | -11.41 |
| Earnings Per Share Diluted | -9.53 | -8.10 | -52.23 | - | -47.26 | -11.41 |
| Weighted Average Shares Outstanding | 3.22 Million | 3.06 Million | 3.06 Million | 3.06 Million | 3.06 Million | 3.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.22 Million | 3.06 Million | 3.06 Million | 3.06 Million | 3.06 Million | 3.06 Million |
| Gross Margin | 0.23 | 0.02 | -0.27 | -0.16 | -0.30 | 0.37 |
| EBIT Margin | 0.00 | -0.07 | -0.47 | - | -0.72 | -0.09 |
| Profit Margin | -0.09 | -0.12 | -0.64 | -0.25 | -0.53 | -0.15 |
| EBITDA | 686 Thousand | -15.48 Million | -118.29 Million | - | -198.9 Million | -19.69 Million |
| Earnings Before Tax Margin | -0.03 | -0.09 | -0.49 | -0.28 | -0.74 | -0.14 |
JAGSNPHARM
6262
WEWIN
300042
INNOCORP
PLLTL